The use of ER stress inducing agents and mTOR inhibitors seems to be the first type of chemotherapy to induce tumor shrinkage in aggressive mouse model of MPNST, making it the most promising therapeutic strategy. The gene discussed is MTOR; the disease is neoplasm.